BRIEF-Aethlon Advances Hemopurifier® Study In Solid Tumors Not Responding To Anti-PD-1 Antibodies

Reuters
29 Jan
BRIEF-Aethlon Advances Hemopurifier® Study In Solid Tumors Not Responding To Anti-PD-1 Antibodies

Jan 29 (Reuters) - Aethlon Medical Inc AEMD.O:

  • AETHLON MEDICAL TREATS FIRST PATIENT IN AUSTRALIAN HEMOPURIFIER® CANCER TRIAL

  • AETHLON MEDICAL : AETHLON ADVANCES HEMOPURIFIER® STUDY IN SOLID TUMORS NOT RESPONDING TO ANTI-PD-1 ANTIBODIES

Source text: ID:nPn8gc5Gna

Further company coverage: AEMD.O

(((( Reuters.briefs@thomsonreuters.com ;));))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10